In an effort to address critical enrollment challenges in clinical research, WCG and Deep 6 AI have teamed up to help connect sites, sponsors and CROs with eligible patients.

The partnership, which will improve trial access and diversity, will arm the thousands of sites, research institutions, sponsors and CROs served by WCG with access to Deep 6’s artificial intelligence-powered software, a real-time platform that securely and precisely connects more than 28 million patients at approximately 2,000 healthcare facilities with trials.

According to WCG and Deep 6, four out of five trials will see delays because of enrollment difficulties. Deep 6’s platform uses artificial intelligence-based methodologies, including machine learning and natural language processing, on structured and unstructured data across multiple healthcare systems to pinpoint eligible patients for trials.